Understanding Immune Cells in Allergies and Autoimmune Conditions
Mechanism of cDC2 subset differentiation in peripheral organs
This project aims to understand how certain immune cells, called cDC2s, develop and function, which could help us find new ways to treat allergies and autoimmune diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11103338 on NIH RePORTER |
What this research studies
Our bodies have special immune cells called conventional dendritic cells (cDCs) that are vital for fighting off infections and maintaining health. This project focuses on a specific type of cDC, called cDC2s, which are important in allergic reactions and autoimmune conditions. We want to learn how different kinds of cDC2s develop and take on their unique roles in the body. By understanding these processes at a basic level, we hope to identify new targets for medicines that could calm overactive immune responses in conditions like allergies.
Who could benefit from this research
Good fit: Patients with allergic diseases or autoimmune conditions might eventually benefit from therapies developed based on this fundamental understanding of immune cells.
Not a fit: Patients without conditions related to allergic or autoimmune immune responses are unlikely to directly benefit from this specific line of basic research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that specifically target problematic immune cells, offering relief for people with allergies and certain autoimmune diseases.
How similar studies have performed: While the general role of cDCs is known, the specific mechanisms governing the differentiation of cDC2 subsets, particularly CD301b+ DCs, are largely unknown, making this a novel area of investigation.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Kumamoto, Yosuke — Rutgers Biomedical and Health Sciences
- Study coordinator: Kumamoto, Yosuke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.